Breakthrough Therapy designation granted based on interim NGN-401 Phase 1/2 data demonstrating clinically meaningful, durable and multidomain functional improvementsOn track to complete dosing in ...
SAE Fellow Election is Fourth Such Recognition for H2 Advisors Founder ARLINGTON, VA, UNITED STATES, February 26, 2026 ...
Schindellegi, Switzerland - 24 February 2026 Trifork Group AGCompany announcement no. 11/2026 Change of reporting segmentation In the upcoming Q4 and Annual Report 2025 on 27 February 2026, Trifork Gr ...
Q4 2025 Management View Seth Grae, President, CEO & Chairman of the Board, characterized 2025 as "a transformative year for Lightbridge," highlighting major fuel development milestones, balance sheet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results